Clinical Trial Update: Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating Adebrelimab in combination with gemcitabine, cisplatin, and simvastatin for advanced biliary tract cancer and is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Tongji Hospital | Conditions: Advanced Biliary Tract Carcinoma | Phase 1, Phase 2 | Status: RECRUITING